Measurement of systemic lupus erythematosus activity in clinical research.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Arthritis & Rheumatism

• Publication date

  1988-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ART.1780310701PMID 3293570
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum deoxyribonuclease I and clinical activity in systemic lupus erythematosus

  2004cited by this paper
• Low plasma androgens in women with systemic lupus erythematosus.

  1987cited by this paper
• Complement fixation by anti-dsDNA antibodies in SLE: measurement by radioimmunoassay and relationship with disease activity.

  1986cited by this paper
• Deficiencies in suppressor T cell activity seen in patients with active systemic lupus erythematosus are due to the dilution of normally functioning suppressor T cells by nonsuppressor T cells.

  1986cited by this paper
• Continuous and discrete global models of disease

  1986cited by this paper
• Identification of moisture sensitivity models of packaged materials under simulated storage conditions

  1986cited by this paper
• Serum complement values (C3 and C4) to differentiate between systemic lupus activity and pre-eclampsia.

  1986cited by this paper
• The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus.

  1985cited by this paper
• Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research.

  1985cited by this paper
• A bibliography of publications on observer variability.

  1985cited by this paper
• Direct stimulation of neutrophil oxygenation activity by serum from patients with systemic lupus erythematosus: a relationship to disease activity.

  1984cited by this paper
• The lupus activity criteria count (LACC).

  1984cited by this paper
• Decreased filtration fraction during active proliferative lupus nephritis: relation to disease activity and reversibility of renal function.

  1984cited by this paper
• Lupus pregnancy. Case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy.

  1984cited by this paper
• Estimating Disease Activity in Rheumatoid Arthritis

  1984cited by this paper
• Inhibition of natural killer cell activity by serum from patients with systemic lupus erythematosus: roles of disease activity and serum interferon.

  1984cited by this paper
• The psychosocial impact of systemic lupus erythematosus and rheumatoid arthritis.

  1984cited by this paper
• Partial purification and characterization of plasma DNA and its relation to disease activity in systemic lupus erythematosus.

  1984cited by this paper
• Antibody to Ro in a population of patients with systemic lupus erythematosus: distribution, clinical and serological associations.

  1983cited by this paper
• Systemic lupus erythematosus activity and IgE.

  1983cited by this paper
• Heterogeneity of antilymphocyte antibody in SLE and its correlation with disease activity.

  1983cited by this paper
• T Lymphocyte Subsets in Systemic Lupus Erythematosus

  1983cited by this paper
• T lymphocyte subsets in systemic lupus erythematosus. Correlations with corticosteroid therapy and disease activity.

  1983cited by this paper
• Complement components, C1 activation and disease activity in SLE.

  1983cited by this paper
• Deficient autologous mixed lymphocyte reactions correlate with disease activity in systemic lupus erythematosus and rheumatoid arthritis.

  1982cited by this paper
• Heterogeneity of immunoregulatory T-cell subsets in systemic lupus erythematosus. Correlation with clinical features.

  1982cited by this paper
• The lupus band test as a measure of disease activity in systemic lupus erythematosus.

  1982cited by this paper
• Useful laboratory measurements in the management of systemic lupus erythematosus.

  1982cited by this paper
• Correlation between clinical activity of systemic lupus erythematosus and the amounts of DNA in DNA/anti-DNA antibody immune complexes.

  1982cited by this paper
• Defective Fc receptor-mediated function of the mononuclear phagocyte system in lupus nephritis.

  1982cited by this paper
• The management of systemic lupus erythematosus.

  1982cited by this paper
• The 1982 revised criteria for the classification of systemic lupus erythematosus.

  1982cited by this paper
• Antibodies to Sm in patients with systemic lupus erythematosus. Correlation of Sm antibody titers with disease activity and other laboratory parameters.

  1981cited by this paper
• Correlation of DNA-anti-DNA association rates with clinical activity in systemic lupus erythematosus (SLE).

  1981cited by this paper
• The value of three immune complex assays in the management of systemic lupus erythematosus: an assessment of immune complex levels, size and immunochemical properties in relation to disease activity and manifestations.

  1980cited by this paper
• Clinical judgment and computers.

  1980cited by this paper
• The C1q binding assay in systemic lupus erythematosus: discordance with disease activity.

  1980cited by this paper
• Clinical judgment and computers.

  1980cited by this paper
• Correlation and predictive accuracy of circulating immune complexes with disease activity in patients with systemic lupus erythematosus.

  1980cited by this paper
• Systemic lupus erythematosus and pregnancy.

  1980cited by this paper
• Correlation of disease activity and Clq-binding immune complexes with the neutrophil inclusions which form in the presence of SLE sera.

  1980cited by this paper
• T? cells in systemic lupus erythematosus

  1979cited by this paper
• A controlled study of pneumococcal polysaccharide vaccine in systemic lupus erythematosus.

  1979cited by this paper
• Central nervous system lupus erythematosus: measurement of cerebrospinal fluid cyclic GMP and other clinical markers of disease activity.

  1979cited by this paper
• A longitudinal study of circulating immune complexes, dna antibodies and complement in patients with systemic lupus erythematosus: an analysis of their relationship to disease activity.

  1979cited by this paper
• Central Nervous System Lupus Erythematosus

  1979cited by this paper
• Tgamma cells in systemic lupus erythematosus. Variation with disease activity.

  1979cited by this paper
• Suppressor-cell antibody in systemic lupus erythematosus. Possible mechanism for suppressor-cell dysfunction.

  1979cited by this paper
• Immunologic findings, thrombocytopenia and disease activity in lupus nephritis.

  1978cited by this paper
• Suppression of C3 rosette formation by serum from patients with systemic lupus erythematosus. A corollary of disease activity.

  1978cited by this paper
• Cell-mediated immunity in systemic lupus erythematosus: observations on in vitro cell-mediated immune responses in relationship to number of potentially reactive T cells, disease activity, and treatment.

  1978cited by this paper
• Activation of blood clotting in patients with systemic lupus erythematosus. Relationship to disease activity.

  1978cited by this paper
• Survival in systemic lupus erythematosus.

  1978cited by this paper
• T-lymphocyte subpopulation in untreated SLE. Variations with disease activity.

  1977cited by this paper
• T‐Lymphocyte Subpopulation in Untreated SLE

  1977cited by this paper
• Peripheral Blood Lymphocytes in Systemic Lupus erythematosus

  1977cited by this paper
• Judgement and causal inference: criteria in epidemiologic studies.

  1977cited by this paper
• Relation of titred peripheral pattern ANA to anti-DNA and disease activity in systemic lupus erythematosus.

  1977cited by this paper
• Relationship of lymphocytotoxic antibodies to lymphopenia and parameters of disease activity in systemic lupus erythematosus.

  1976cited by this paper
• Relationship of lymphocytotoxic antibodies to lymphopenia and parameters of disease activity in systemic lupus erythematosus.

  1976cited by this paper
• Systemic lupus erythematosus in childhood correlations between changes in disease activity and serum complement levels.

  1976cited by this paper
• Depression of cellular-mediated immunity in systemic lupus erythematosus. relation to disease activity.

  1975cited by this paper
• Assessment of activity in SLE: a clinical and serological study.

  1975cited by this paper
• Proceedings: Circulating complexes and disease activity in SLE.

  1975cited by this paper
• Lymphocyte tubuloreticular structures in lupus erythematosus. Correlation with disease activity.

  1974cited by this paper
• Proceedings: Lymphocyte tubuloreticular structures--disease activity correlation and sequential studies in systemic lupus erythematosus.

  1974cited by this paper
• Systemic lupus erythematosus with cutaneous ulceration. Correlation of immunologic factors with therapy and clinical activity.

  1971cited by this paper
• Immunologic factors and clinical activity in systemic lupus erythematosus.

  1968cited by this paper
• The relation of immunoglobulin class, pattern of anti-nuclear antibody, and complement-fixing antibodies to DNA in sera from patients with systemic lupus erythematosus.

  1967cited by this paper
• Relation of positive L.E.-cell preparations to activity of lupus erythematosus and corticosteroid therapy.

  1962cited by this paper
• Therapeutic criteria in rheumatoid arthritis.

  1949cited by this paper

• Serum Vitamin D Level and Disease Activity in Patients With Systemic Lupus Erythematosus

  2025cites this paper
• Patients with systemic lupus erythematosus (SLE) have an increased bisphenol A methylation score linked to SLE risk genes and selected clinical subphenotypes

  2025cites this paper
• Defining the physician global assessment threshold equivalent to remission in patients with systemic lupus erythematosus.

  2023cites this paper
• Biomarkers in Neuropsychiatric Systemic Lupus Erythematosus: A Systematic Literature Review of the Last Decade

  2022cites this paper
• Inflammatory markers in saliva and urine reflect disease activity in patients with systemic lupus erythematosus

  2022cites this paper
• Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS study.

  2022cites this paper
• Monitoring disease activity

  2021cites this paper
• Four Systemic Lupus Erythematosus Subgroups, Defined by Autoantibodies Status, Differ Regarding HLA‐DRB1 Genotype Associations and Immunological and Clinical Manifestations

  2021cites this paper
• Instruments for Outcome Evaluation of Specific Domains in Primary Sjögren’s Syndrome

  2021cites this paper
• The binding of SLE autoantibodies to mitochondria.

  2020cites this paper
• Which is the best SLE activity index for clinical trials?

  2020cites this paper
• Use of Physician Global Assessment (PGA) in Systemic lupus erythematosus: a systematic review of its psychometric properties

  2020influential citation
• МЕТОДИКА ВИЗНАЧЕННЯ ФУНКЦІОНАЛЬНОГО КЛАСУ ХВОРОГО НА СИСТЕМНИЙ ЧЕРВОНИЙ ВОВЧАК

  2020cites this paper
• МЕТОДИКА ВИЗНАЧЕННЯ ФУНКЦІОНАЛЬНОГО КЛАСУ ХВОРОГО НА СИСТЕМНИЙ ЧЕРВОНИЙ ВОВЧАК

  2020cites this paper
• Use of Physician Global Assessment in systemic lupus erythematosus: a systematic review of its psychometric properties.

  2020cites this paper
• Systemic lupus erythematosus in the intensive care unit: a systematic review

  2020cites this paper
• Sjögren Syndrome in Systemic Lupus Erythematosus: A Subset Characterized by a Systemic Inflammatory State

  2020cites this paper
• 9th Annual Meeting of the Lupus Academy Meeting Report

  2019cites this paper
• Microparticles in the blood of patients with SLE: Size, content of mitochondria and role in circulating immune complexes.

  2019cites this paper
• High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus

  2019cites this paper
• New recommendations for the classification and management of systemic lupus erythematosus

  2019cites this paper
• Role of Histopathology in Diagnosis of Cutaneous Lupus Erythematosus: A Cross Sectional Observational Study

  2019cites this paper
• The Association Between Erythrocyte Sedimentation Rate, C3, C4, Anti-dsDNA Levels, and Renal Disease Activity, Based on BILAG Index in Females With Lupus Nephritis

  2018cites this paper
• Progressive reduction of serum complement levels: a risk factor for relapse in patients with hypocomplementemia in systemic lupus erythematosus

  2018cites this paper
• Sensitivity analyses of four systemic lupus erythematosus disease activity indices in predicting the treatment changes in consecutive visits: a longitudinal study

  2018cites this paper
• University of Michigan 2014-02 Population-Based Incidence and Prevalence of Systemic Lupus Erythematosus : The Michigan

  2018cites this paper
• IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE)

  2017cites this paper
• A comparison of patients’ and physicians’ assessments of disease activity using the Swedish version of the Systemic Lupus Activity Questionnaire

  2017cites this paper
• Targeting the interferon pathway with sifalimumab for the treatment of systemic lupus erythematosus.

  2017cites this paper
• ErythematosusPatients with Systemic Lupus by Lymphocytes β Decreased Production of TGF

  2017cites this paper
• Biomarkers of disease activity and organ damage in systemic lupus erythematosus

  2017influential citation
• Excess atherosclerosis in systemic lupus erythematosus,—A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls

  2017cites this paper
• Association between diet and treatment results in patients with rheumatoid arthritis and systemic lupus erythematosus

  2016influential citation
• Microparticles in the blood of patients with systemic lupus erythematosus (SLE): phenotypic characterization and clinical associations

  2016cites this paper
• Is there still a place for erythrocyte sedimentation rate and C-reactive protein in systemic lupus erythematosus?

  2016cites this paper
• Multiparametric detection of autoantibodies in systemic lupus erythematosus

  2016cites this paper
• Progress in defining clinically meaningful changes for clinical trials in nonrenal manifestations of SLE disease activity

  2016cites this paper
• Signal transducer and activator of transcription 5 is implicated in disease activity in adult and juvenile onset systemic lupus erythematosus

  2016cites this paper
• Lifestyle habits and fatigue among people with systemic lupus erythematosus and matched population controls

  2015cites this paper
• Predictors of arthritis in pediatric patients with lupus

  2015cites this paper
• Intractable Headaches, Ischemic Stroke, and Seizures Are Linked to the Presence of Anti-β2GPI Antibodies in Patients with Systemic Lupus Erythematosus

  2015cites this paper
• Measuring disease activity in adults with systemic lupus erythematosus: the challenges of administrative burden and responsiveness to patient concerns in clinical research

  2015cites this paper
• Serum neuron specific enolase – a novel indicator for neuropsychiatric systemic lupus erythematosus?

  2015cites this paper
• articleEndothelial cell markers reflecting endothelial cell dysfunction in patients with mixed connective tissue disease

  2015cites this paper
• Expression of Toll-Like Receptors 3, 7, and 9 in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus

  2014cites this paper
• The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease

  2014cites this paper
• Why and how should we measure disease activity and damage in lupus?

  2014influential citation
• Population‐Based Incidence and Prevalence of Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program

  2014cites this paper
• Cardiovascular Disease and Immune Mechanisms in Systemic Lupus Erythematosus

  2014cites this paper
• MEDICINSKI FAKULTET SVEUČILIŠTA U ZAGREBU

  2014cites this paper
• Cigarette smoking, antiphospholipid antibodies and vascular events in Systemic Lupus Erythematosus

  2014cites this paper
• Cutaneous lupus erythematosus: diagnosis and treatment.

  2013cites this paper
• A Research Study of the Association between Maternal Microchimerism and Systemic Lupus Erythematosus in Adults: A Comparison between Patients and Healthy Controls Based on Single-Nucleotide Polymorphism Using Quantitative Real-Time PCR

  2013cites this paper
• Revista Cubana de Reumatología

  2013cites this paper
• New-onset systemic lupus erythematosus during pregnancy

  2013cites this paper
• Sjogren's syndrome.

  2013cites this paper
• Prevalence of nonspecific cutaneous vascular lesions and association with antiphospholipid antibodies in patients with systemic lupus erythematosus

  2013cites this paper
• Современные методы оценки активности системной красной волчанки

  2013cites this paper
• Measuring fatigue in SSc: a comparison of the Short Form-36 Vitality subscale and Functional Assessment of Chronic Illness Therapy-Fatigue scale.

  2012cites this paper
• Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study

  2012influential citation
• An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life

  2012influential citation
• Studies on cardiovascular risk factors in Systemic Lupus Erythematosus

  2012cites this paper
• Vitamin D insufficiency in a large MCTD population.

  2011cites this paper
• Measurement of Chronicity and Activity in Sjögren’s Syndrome

  2011cites this paper
• Social support and health in patients with systemic lupus erythematosus: A literature review

  2011cites this paper
• Studies of atherosclerosis in systemic lupus erythematosus

  2011cites this paper
• Monitoring Disease Activity

  2011cites this paper
• SKIN LESIONS IN LUPUS ERYTHEMATOSUS: A MARKER OF SYSTEMIC INVOLVEMENT

  2011cites this paper
• Psychiatric disorders in patients with systemic lupus erythematosus: association of anxiety disorder with shorter disease duration

  2010cites this paper
• Connective Tissue Diseases

  2010cites this paper
• Retraction Note to: Correlation of ESR, C3, C4, anti-DNA and lupus activity based on British Isles Lupus Assessment Group Index in patients of rheumatology clinic

  2010cites this paper
• Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience.

  2010cites this paper
• Endothelial cell markers reflecting endothelial cell dysfunction in patients with mixed connective tissue disease

  2010cites this paper
• RETRACTED ARTICLE: Correlation of ESR, C3, C4, anti-DNA and lupus activity based on British Isles Lupus Assessment Group Index in patients of rheumatology clinic

  2010cites this paper
• A Cohort study of exposure controlled mycopenolic acid in class iii and class IV lupus nephritis in a tertiary care centre in South India.

  2010cites this paper
• Non-specific vascular skin lesions in the course of systemic lupus erythematosus

  2010cites this paper
• Is Serum Albumin a Marker of Malnutrition in Chronic Disease? The Scleroderma Paradigm

  2010cites this paper
• Monoclonal antibodies in the treatment of systemic lupus erythematosus.

  2009cites this paper
• Assessment of disease activity and quality of life in systemic lupus erythematosus - New aspects.

  2009cites this paper
• A prospective study of protein excretion using short-interval timed urine collections in patients with lupus nephritis.

  2009cites this paper
• Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study

  2009influential citation
• A controlled comparison of brachial artery flow mediated dilation (FMD) and digital pulse amplitude tonometry (PAT) in the assessment of endothelial function in systemic lupus erythematosus

  2009cites this paper
• The Cutaneous Lupus Erythematosus Disease Activity and Severity Index: expansion for rheumatology and dermatology.

  2008cites this paper
• Diagnostic accuracy study of urine dipstick in relation to 24-hour measurement as a screening tool for proteinuria in lupus nephritis.

  2008cites this paper
• Sleep and Systemic Lupus Erythematosus

  2008cites this paper
• [Hematopoietic stem cell transplantation in autoimmune diseases].

  2008cites this paper
• Measurement of disease activity and damage in Sjögren's syndrome.

  2008cites this paper
• Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus

  2008cites this paper
• Endothelial function and markers of endothelial activation in relation to cardiovascular disease in systemic lupus erythematosus

  2008influential citation
• Development and validation of the BILAG-2004 index for the assessment of disease activity in systemic lupus erythematosus.

  2008cites this paper
• Trasplante de células progenitoras hematopoyéticas en enfermedades autoinmunes

  2008cites this paper
• New therapies in systemic lupus erythematosus – trials, troubles and tribulations…. working towards a solution

  2008cites this paper
• Evaluation of the Cutaneous Lupus Activity and Severity Score in the assessment of lupus erythematosus skin disease

  2007cites this paper
• British isles lupus assessment group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus

  2007cites this paper
• BILAG-2004 index captures systemic lupus erythematosus disease activity better than SLEDAI-2000

  2007cites this paper
• Discordance between erythrocyte sedimentation rate and C-reactive protein measurements: clinical significance.

  2007cites this paper
• Screening for proteinuria in patients with lupus: a survey of practice preferences among American rheumatologists.

  2007cites this paper
• Update on indices of disease activity in systemic sclerosis.

  2007cites this paper
• Sjögren's Systemic Clinical Activity Index (SCAI)--a systemic disease activity measure for use in clinical trials in primary Sjögren's syndrome.

  2007cites this paper
• A pravastatin dose-escalation study in systemic lupus erythematosus

  2007influential citation